IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety
Joint Authors
Grube, Barbara
Bongartz, Udo
Alt, Felix
Source
Evidence-Based Complementary and Alternative Medicine
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-05-17
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
The individual ingredients in IQP-VV-102 have demonstrated promising effects in reducing sugar and starch digestion, which potentially leads to weight loss.
The trial objective was to evaluate the safety and efficacy of IQP-VV-102 in reducing body weight in overweight and obese subjects.
120 overweight and obese individuals aged 18 to 60 years were randomly assigned to 2 treatment arms (IQP-VV-102 and placebo).
The trial was conducted in 2 study centres in Berlin, Germany.
The primary efficacy analysis was conducted on 117 subjects (IQP-VV-102: N=54; placebo: N=59), comparing the weight loss effect at baseline and 12 weeks after randomization.
There was a statistically significant reduction in mean body weight of 3.29 kg (SD 2.30) in the IQP-VV-102 group compared to 0.83 kg (SD 2.00) in the placebo group p<0.001.
There were no serious or product-related adverse events that were reported over the combined period of 14 weeks.
The findings suggested that IQP-VV-102 is effective and safe in body weight reduction in overweight and obese individuals in the short term.
The study is registered under clinicaltrials.gov as NCT01681069.
American Psychological Association (APA)
Grube, Barbara& Bongartz, Udo& Alt, Felix. 2015. IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety. Evidence-Based Complementary and Alternative Medicine،Vol. 2015, no. 2015, pp.1-7.
https://search.emarefa.net/detail/BIM-1061476
Modern Language Association (MLA)
Grube, Barbara…[et al.]. IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety. Evidence-Based Complementary and Alternative Medicine No. 2015 (2015), pp.1-7.
https://search.emarefa.net/detail/BIM-1061476
American Medical Association (AMA)
Grube, Barbara& Bongartz, Udo& Alt, Felix. IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety. Evidence-Based Complementary and Alternative Medicine. 2015. Vol. 2015, no. 2015, pp.1-7.
https://search.emarefa.net/detail/BIM-1061476
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1061476